Drugs / simagliptin
last change Dec 2025 re-read 2 minutes ago

simagliptin

Developed for
chronic kidney disease · obesity disorder
Investigated by
RenJi Hospital

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT06344247 Sep 2023 → Sep 2025 chronic kidney disease, obesity disorder RenJi Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as simagliptin ClinicalTrials.gov intervention name — accepted as the source's own label NCT06344247